Scientists in the US have now shown that TGF-β triggers the formation of a protein known as disabled-2 (Dab2) which, in turn, activates the EMT process. An increased understanding of the signalling pathway for modulating EMT could lead to the design of drugs to delay or halt EMT and control tumour metastasis. The discovery may also help to understand the progression of other diseases.
The study is published in Nature Cell Biology.
Related posts:
- Stopping Cancer Spread The deadliest feature of cancer is its ability to spread, or metastasise. Migrastatin, a compound isolated from Streptomyces, was found...
- Suppressing ROCK May Prevent Breast Cancer Metastases Nearly half of all patients treated for apparently localised breast cancer develop metastatic disease. Although there are treatment options that...
- Targeting Breast Cancer Stem Cells Cancer stem cells (CSCs) have been identified in a variety of tumour types, including breast tumours, and have been proposed...
- Syk Protective Against Breast Cancer Inhibitors of the non-receptor spleen tyrosine kinase (Syk) are being developed to treat a variety of allergic and autoimmune disorders,...
- Salinomycin Selectively Attacks Breast Cancer Stem Cells There is growing evidence for a subpopulation of cells in breast cancer, known as breast cancer stem cells, that may...
Related posts brought to you by Yet Another Related Posts Plugin.
This entry was posted on Thursday, February 18th, 2010 at 8:59 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
















Entries (RSS)